🍁Based in Canada. Fully manufactured in Canada.
Tesamorelin — 20 mg
Tesamorelin — 20 mg - Image 2

Tesamorelin — 20 mg

View Certificate of Analysis Independent third‑party lab report · PDF

Additional information

Package

Single Pen, 3x Pens, 10x Pens, Single Vial, 3x Vials, 10x Vials
⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About Tesamorelin

ClassificationGrowth hormone-releasing factor
CAS Registry218949-48-5
Molecular Mass5135.9
Residue Count44
Chain SequenceTyr-D-Ala-Ala-Ala
Molecular FormulaC221H366N72O67S
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Journal of Clinical Endocrinology & Metabolism

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients

2009 • PMID: 19846735

Falutz J, Allas S, Blot K, Potvin D, Kotler D

Read Paper ↗
AIDS

Tesamorelin treatment reduces visceral fat and improves metabolic parameters in HIV-infected patients

2010 • PMID: 20588173

Falutz J, Allas S, Blot K, Potvin D, Kotler D

Read Paper ↗
Lancet

Tesamorelin for the treatment of excess abdominal fat in HIV-infected patients

2010 • PMID: 20656467

Falutz J, Allas S, Blot K, Potvin D, Kotler D

Read Paper ↗

Related products